» Articles » PMID: 39766544

Isolation and Characterization of Lytic Phages Infecting Clinical from Tunisia

Overview
Specialty Pharmacology
Date 2025 Jan 8
PMID 39766544
Authors
Affiliations
Soon will be listed here.
Abstract

: is an opportunistic pathogen that causes a wide range of infections worldwide. The emergence and spread of multidrug-resistant clones requires the implementation of novel therapeutics, and phages are a promising approach. : In this study, two phages, KpTDp1 and KpTDp2, were isolated from wastewater samples in Tunisia. These phages had a narrow host range and specifically targeted the hypervirulent K2 and K28 capsular types of . Both phages have double-stranded linear DNA genomes of 49,311 and 49,084 bp, respectively. Comparative genomic and phylogenetic analyses placed phage KpTDp2 in the genus , while phage KpTDp1 showed some homology with members of the genus , although its placement in a new undescribed genus may be reconsidered. The replication efficiency and lytic ability of these phages, combined with their high stability at temperatures up to 70 °C and pH values ranging from 3.5 to 8.2, highlight the potential of these phages as good candidates for the control of hypervirulent multidrug-resistant . : Phage isolation, titration and multiplicity of infection were performed. The stability of KpTDp1 and KpTDp2 was tested at different pH and temperatures. Genomic characterization was done by genome sequencing, annotation and phylogenetic analysis. : The ability of KpTDp1 and KpTDp2 to lyse one of the most virulent serotypes of , as well as the stability of their lytic activities to pH and temperature variations, make these phages promising candidates for antibacterial control.

References
1.
Liang B, Zhao W, Han B, Barkema H, Niu Y, Liu Y . Biological and genomic characteristics of two bacteriophages isolated from sewage, using one multidrug-resistant and one non-multidrug-resistant strain of . Front Microbiol. 2022; 13:943279. PMC: 9608510. DOI: 10.3389/fmicb.2022.943279. View

2.
Messaoudi A, Mansour W, Jaidane N, Chaouch C, Boujaafar N, Bouallegue O . Epidemiology of resistance and phenotypic characterization of carbapenem resistance mechanisms in isolates at Sahloul University Hospital-Sousse, Tunisia. Afr Health Sci. 2019; 19(2):2008-2020. PMC: 6794520. DOI: 10.4314/ahs.v19i2.24. View

3.
Jo S, Kwon J, Kim S, Lee S . The Biotechnological Application of Bacteriophages: What to Do and Where to Go in the Middle of the Post-Antibiotic Era. Microorganisms. 2023; 11(9). PMC: 10534921. DOI: 10.3390/microorganisms11092311. View

4.
Kropinski A, Mazzocco A, Waddell T, Lingohr E, Johnson R . Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol. 2008; 501:69-76. DOI: 10.1007/978-1-60327-164-6_7. View

5.
Peng J, Guo C, Yang C, Zhang L, Yang F, Huang X . Phage therapy for bone and joint infections: A comprehensive exploration of challenges, dynamics, and therapeutic prospects. J Glob Antimicrob Resist. 2024; 39:12-21. DOI: 10.1016/j.jgar.2024.07.007. View